A Study of PHN-012 in Patients With Advanced Solid Tumors
Pheon Therapeutics
Pheon Therapeutics
Kestrel Therapeutics, Inc.
Boehringer Ingelheim
Zymeworks BC Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Nammi Therapeutics Inc
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Pfizer
Revolution Medicines, Inc.
Conjupro Biotherapeutics, Inc.
Alterome Therapeutics, Inc.
National Cancer Institute (NCI)
SystImmune Inc.
Pfizer
Institut Paoli-Calmettes
RasCal Therapeutics, Inc.
Eli Lilly and Company
Pfizer
Tomsk National Research Medical Center of the Russian Academy of Sciences
Xencor, Inc.
ViroMissile, Inc.
Replimune Inc.
Pfizer
Pfizer
Tizona Therapeutics, Inc
National Institutes of Health Clinical Center (CC)
Baylor College of Medicine
Nanjing Sanhome Pharmaceutical, Co., Ltd.
Revolution Medicines, Inc.
SystImmune Inc.
Pheon Therapeutics
National Cancer Institute (NCI)
Eli Lilly and Company
Seagen Inc.
Phrontline Biopharma
AgonOx, Inc.
Novartis
Seagen Inc.
Shanghai Juncell Therapeutics
Degron Therapeutics Co.
University Health Network, Toronto
AstraZeneca
Chongqing Precision Biotech Co., Ltd
Turning Point Therapeutics, Inc.
HUYABIO International, LLC.
National Institutes of Health Clinical Center (CC)
Sanofi
Revolution Medicines, Inc.
GONGCHU Biotechnology Co., Ltd